Christopher Guerreiro Norton Rose Fulbright


Christopher Guerreiro practises contentious intellectual property dispute resolution and litigation, with an emphasis on patents and issues affecting the life sciences, healthcare, and other high-technology industries. Mr. Guerreiro has particular experience with complex pharmaceutical and medical-device patent infringement and impeachment actions, as well as prohibition and damages proceedings under the Patented Medicines (Notice of Compliance) Regulations. He also advises on intellectual property-related regulatory structures affecting the life sciences industries, such as the Patented Medicine Prices Review Board. Mr. Guerreiro brings a practical, business-focused approach to his practice, relying on over four years of pre-law experience in pharmaceutical clinical and commercial operations and his education in biology. During his articles, Mr. Guerreiro gained additional perspective on the commercial and regulatory dimensions of the innovative pharmaceutical industry while on secondment to the in-house legal team at GlaxoSmithKline. While studying at Osgoode Hall Law School, Mr. Guerreiro was recognized for achieving top standing in areas including evidence, civil procedure, conflict of laws, business law, and contracts, and graduated second in his class. Mr. Guerreiro has continued his involvement with Osgoode as a member of the upper-year theory and practice of negotiation teaching team. Mr. Guerreiro joined our Toronto office as a summer student in 2011 and returned as an articling student in 2012–2013.

2020 Awards


Nominee, 2020 Antitrust Writing Awards: Business, Intellectual Property

Send a message